Table 1.
Reference | SCI animal model | Materials for scaffold | Applied cells | Recovery time | Tests for motor function | Functional outcome | BBB score | ||
---|---|---|---|---|---|---|---|---|---|
ltosaka et al., 2009 | Rat | T8 | Hemisection | Fibrin fibers | BMSC | 4 weeks | BBB | Improved | 15 |
Okuda, 2017 | T8 | Transection | Cell sheet | 4 weeks | BBB | Improved | 5 | ||
Kang et al., 2011 | T8-9 | Transection | PLGA scaffold | MSC | 4 weeks | BBB | Improved | 10 | |
Yang, 2017 | T9-10 | Transection | PLGA scaffold | 4 weeks | BBB | Improved | 7 | ||
Hejcl et al., 2010 | T8-9 | Compression | HPMA-RGD hydrogel | 35 weeks | BBB, plantar test | Improved | 10 | ||
Hatami et al., 2009 | T10 | Hemisection | Type1 collagen droplet | NSC | 5 weeks | BBB | Improved | 19 | |
Nomura et al., 2008 | T8 | Transection | Chitosan channels | 12 weeks | BBB | No effect | 9 | ||
Bozkurt et al., 2010 | T8 | Compression | 9 weeks | BBB | No effect | 11 | |||
Teng et al., 2002 | T9-10 | Hemisection | PLGA scaffold | 10 weeks | BBB | Improved | 10 | ||
Du et al., 2011 | T9-10 | Transection | 8 weeks | BBB, Incline test | Improved | 9 | |||
Johnson et al., 2010 | T9 | Hemisection | Fibrin scaffold | 8 weeks | BBB, Grid walk | No effect | Data not shown | ||
Ye, 2016 | T10 | Contrusion | Self-assembling peptide nanofiber | 5 weeks | BBB | Improved | 12 | ||
Mothes, 2013 | T2 | Compression | Hyaluronan-methy cellulose gel | 9 weeks | BBB | No effect | 12 | ||
Liu et al., 2015 | T10 | Transection | PLGA scaffold | iNSC | 10 weeks | BBB | Improved | 14 | |
PLGA-PEG scaffold | 10 weeks | BBB | Improved | 17 | |||||
Olson et al., 2009 | T8-9 | Transection | PLGA scaffold | SC | 4 weeks | BBB | No effect | 1 | |
Wang et al., 2011 | T10 | Transection | Gelform | 8 weeks | BBB, incline test | Improved | 8 | ||
Hurtado et al., 2006 | T9-10 | Transection | PDL tubular scaffold | 6 weeks | BBB | No effect | 7 | ||
Joosten et al., 2004 | T7-9 | Transection | Collagen gel | Astrocyte | 4 weeks | BBB, grid, catwalk | No effect | 13 | |
Rochkind et al., 2006 | T7–8 | Transection | Dextran-gelatin tube | NOM, SCC | 12 weeks | BBB | No effect | 10 | |
Zhang et al., 2016 | T9 | Contrusion | Chitosan scaffold | hDPSC | 4 weeks | BBB | Improved | 12 | |
Pritchard et al., 2010 | Primate | T9 | Hemisection | PLGA scaffold | NSC | 6 weeks | Babu scale | Improved | 15 |
Nemati, 2013 | C5–L1 | Contrusion | Direct injection | 49 weeks | Tarlov's scale | Improved | 1.75 |
T: thoracic; C: cervical; L: lumbar; PLGA: poly(lactide-co-glycolide) acid; HPMA-RGD: N-(2-hydroxypropyl)-methacrylamide with attached amino acid sequences Arg-Gly-Asp; PDL: poly D-lactic acid; PLA: poly L-lactic acid; BMSC: bone marrow stromal cell; MSC: mesenchymal stem cells; NSC: neural stem cell; iNSC: induced neural stem cell; SC: Schwann cell; NOM: nasal olfactory mucosal cell; SCC: spinal cord cell; BBB: Basso, Beattie, and Bresnahan test scale.